Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Neisseria gonorrhoeae Monoclonal Antibody (GC12-323.6), Invitrogen™
Mouse Monoclonal Antibody
Supplier: Thermo Scientific MA110715
Description
MA1-10715 detects Neisseria gonorrhoeae. MA1-10715 has been successfully used in ELISA applications. The MA1-10715 immunogen is UV-inactivated Neisseria gonorrhoeae cells W-I, W-II, W-III.
Although pathogenic bacteria constitute only a small portion of bacterial species, infectious diseases caused by pathogenic bacteria affect millions of people worldwide. Diarrheal diseases, many of which are bacterial, are the second leading cause of death worldwide, claiming an estimated 5 million people annually. Furthermore, an estimated 3 million people die of tuberculosis annually, 500,000 people die of pertussis, and 25,000 die of typhoid. The ability of bacteria to utilize various food sources is a major factor behind their pervasiveness. Their vast numbers lead to rapid evolutionary changes resulting in emerging diseases as well as antibiotic-resistant strains of well known diseases. Examples of these are multi-drug resistant tuberculosis and methicillin-resistant Staphylococcus aureus. Research into the detection and treatment of these infectious disease agents will continue to expand in an effort to alleviate the effects of these diseases.
Specifications
Neisseria gonorrhoeae | |
Monoclonal | |
1.4 mg/mL | |
PBS with no preservative; pH 7.4 | |
Mouse | |
Protein G | |
RUO | |
Bacteria | |
Antibody | |
IgG1 |
ELISA | |
GC12-323.6 | |
Unconjugated | |
Gonococci; N. gonorrhoeae | |
UV-inactivated Neisseria gonorrhoeae cells W-I, W-II, W-III. | |
500 μg | |
Primary | |
-20° C, Avoid Freeze/Thaw Cycles | |
Liquid |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction